FZMD
Price
$0.12
Change
+$0.07 (+140.00%)
Updated
Dec 10 closing price
GNGBY
Price
$15.83
Change
+$0.14 (+0.89%)
Updated
Dec 20 closing price
Ad is loading...

FZMD vs GNGBY

Header iconFZMD vs GNGBY Comparison
Open Charts FZMD vs GNGBYBanner chart's image
Fuse Medical
Price$0.12
Change+$0.07 (+140.00%)
Volume$55.05K
CapitalizationN/A
Getinge AB
Price$15.83
Change+$0.14 (+0.89%)
Volume$75.18K
CapitalizationN/A
FZMD vs GNGBY Comparison Chart
Loading...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FZMD vs. GNGBY commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FZMD is a Hold and GNGBY is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (FZMD: $0.12 vs. GNGBY: $15.83)
Brand notoriety: FZMD and GNGBY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FZMD: 404% vs. GNGBY: 159%
Market capitalization -- FZMD: $5.99M vs. GNGBY: $5.07B
FZMD [@Medical Specialties] is valued at $5.99M. GNGBY’s [@Medical Specialties] market capitalization is $5.07B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FZMD’s FA Score shows that 0 FA rating(s) are green whileGNGBY’s FA Score has 1 green FA rating(s).

  • FZMD’s FA Score: 0 green, 5 red.
  • GNGBY’s FA Score: 1 green, 4 red.
According to our system of comparison, both FZMD and GNGBY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FZMD’s TA Score shows that 5 TA indicator(s) are bullish while GNGBY’s TA Score has 5 bullish TA indicator(s).

  • FZMD’s TA Score: 5 bullish, 3 bearish.
  • GNGBY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FZMD is a better buy in the short-term than GNGBY.

Price Growth

FZMD (@Medical Specialties) experienced а 0.00% price change this week, while GNGBY (@Medical Specialties) price change was +0.25% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.55%. For the same industry, the average monthly price growth was +0.22%, and the average quarterly price growth was +2.20%.

Industries' Descriptions

@Medical Specialties (-0.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNGBY($5.07B) has a higher market cap than FZMD($5.99M). GNGBY has higher P/E ratio than FZMD: GNGBY (24.88) vs FZMD (1.73). FZMD YTD gains are higher at: 4.261 vs. GNGBY (-27.433). GNGBY has higher annual earnings (EBITDA): 5.41B vs. FZMD (3.7M). GNGBY has more cash in the bank: 4.43B vs. FZMD (211K). FZMD has less debt than GNGBY: FZMD (2.08M) vs GNGBY (6.89B). GNGBY has higher revenues than FZMD: GNGBY (29.8B) vs FZMD (18.1M).
FZMDGNGBYFZMD / GNGBY
Capitalization5.99M5.07B0%
EBITDA3.7M5.41B0%
Gain YTD4.261-27.433-16%
P/E Ratio1.7324.887%
Revenue18.1M29.8B0%
Total Cash211K4.43B0%
Total Debt2.08M6.89B0%
FUNDAMENTALS RATINGS
FZMD vs GNGBY: Fundamental Ratings
FZMD
GNGBY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
6
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10082
PRICE GROWTH RATING
1..100
3462
P/E GROWTH RATING
1..100
4144
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GNGBY's Valuation (6) in the null industry is somewhat better than the same rating for FZMD (54). This means that GNGBY’s stock grew somewhat faster than FZMD’s over the last 12 months.

GNGBY's Profit vs Risk Rating (100) in the null industry is in the same range as FZMD (100). This means that GNGBY’s stock grew similarly to FZMD’s over the last 12 months.

GNGBY's SMR Rating (82) in the null industry is in the same range as FZMD (100). This means that GNGBY’s stock grew similarly to FZMD’s over the last 12 months.

FZMD's Price Growth Rating (34) in the null industry is in the same range as GNGBY (62). This means that FZMD’s stock grew similarly to GNGBY’s over the last 12 months.

FZMD's P/E Growth Rating (41) in the null industry is in the same range as GNGBY (44). This means that FZMD’s stock grew similarly to GNGBY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FZMDGNGBY
RSI
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
53%
Momentum
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
55%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
67%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
59%
Bullish Trend 5 days ago
70%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
69%
View a ticker or compare two or three
Ad is loading...
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNGBY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEQIX24.190.31
+1.30%
Pioneer Equity Income A
BSVIX16.440.19
+1.17%
Baird Equity Opportunity Institutional
CVTCX51.230.40
+0.79%
Calamos Growth & Income C
ARTKX47.140.12
+0.26%
Artisan International Value Investor
JUSOX26.26-0.57
-2.12%
JHancock New Opportunities R4

FZMD and

Correlation & Price change

A.I.dvisor tells us that FZMD and GNGBY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
GNGBY - FZMD
16%
Poorly correlated
+0.89%
DSRLF - FZMD
9%
Poorly correlated
N/A
GNNDY - FZMD
7%
Poorly correlated
N/A
FSPKF - FZMD
6%
Poorly correlated
N/A
HTLZF - FZMD
6%
Poorly correlated
N/A
More

GNGBY and

Correlation & Price change

A.I.dvisor tells us that GNGBY and CNMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
+0.89%
CNMD - GNGBY
32%
Poorly correlated
-1.68%
ALGN - GNGBY
29%
Poorly correlated
-1.18%
AVNS - GNGBY
28%
Poorly correlated
-2.78%
SNN - GNGBY
27%
Poorly correlated
-0.52%
AEMD - GNGBY
26%
Poorly correlated
+33.83%
More